Product Information
MIGRAINE FORMULA CAPLET is a generic product labeled by AmerisourceBergen, priced at $0.0648 per EA under NDC 24385036578. Its NADAC has been published 671 times since Nov 28, 2013.
FDA first approved this application on Nov 26, 2001.
Strength
250; 250; 65 mg/1; mg/1; mg/1
Manufacturer
AmerisourceBergenNDC
24385036578
Classification
Generic
Dosage Form
TABLET, FILM COATED
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
ACETAMINOPHEN; ASPIRIN; CAFFEINEApproval Type
Generic (ANDA)
FDA Application
ANDA075794FDA Approved
11/26/2001
On Market Since
5/13/2002
Pharmacological Classes
Price Statistics
The NADAC for MIGRAINE FORMULA CAPLET has been published 671 times since Nov 28, 2013, and over the history we have for it it has risen 43.3%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0648 per EA |
|---|---|
| All-time high | $0.0698 (Sep 11, 2024) |
| All-time low | $0.0359 (May 18, 2016) |
| 52-week high | $0.0691 |
| 52-week low | $0.0635 |
| Median price | $0.0566 |
| Average price | $0.0567 |
| Largest weekly change | +34.6% (Jul 20, 2016) |
| Weeks tracked | 671 |
| Tracking since | Nov 28, 2013 |
Generic Alternatives
The matcher finds 6 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
AmerisourceBergen manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Acetaminophen, Aspirin, Caffeine market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Central Nervous System Stimulant class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of MIGRAINE FORMULA CAPLET?
The current National Average Drug Acquisition Cost (NADAC) for MIGRAINE FORMULA CAPLET, manufactured by AmerisourceBergen, is $0.0648 per EA (NDC 24385036578), effective Sep 30, 2026.
How has the price of MIGRAINE FORMULA CAPLET changed over time?
Over the history we have for it, the NADAC for MIGRAINE FORMULA CAPLET has risen 43.3%. It has been tracked across 671 weekly CMS publications since Nov 28, 2013.
What are the highest and lowest recorded NADAC prices for MIGRAINE FORMULA CAPLET?
Since Nov 28, 2013, the NADAC for MIGRAINE FORMULA CAPLET has ranged from a low of $0.0359 (May 18, 2016) to a high of $0.0698 (Sep 11, 2024), with a median of $0.0566 per EA.
Are there cheaper alternatives to MIGRAINE FORMULA CAPLET?
6 manufacturers publish a NADAC-priced product with the same active ingredient and strength as MIGRAINE FORMULA CAPLET in a comparable dosage form, but none are currently priced below it.
Who manufactures MIGRAINE FORMULA CAPLET?
MIGRAINE FORMULA CAPLET (NDC 24385036578) is labeled by AmerisourceBergen, and CMS classifies it as a generic product.